Allscripts Healthcare Solutions (NASDAQ:MDRX) Price Target Cut to $19.00 by Analysts at Piper Sandler


Allscripts Healthcare Solutions (NASDAQ:MDRXGet Rating) had its price objective reduced by equities research analysts at Piper Sandler from $22.00 to $19.00 in a research report issued on Friday, The Fly reports. Piper Sandler’s target price would indicate a potential downside of 4.38% from the stock’s previous close.

Other research analysts also recently issued research reports about the company. SVB Leerink upped their target price on Allscripts Healthcare Solutions from $22.00 to $24.00 and gave the stock an “outperform” rating in a report on Thursday, March 3rd. StockNews.com downgraded Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a report on Monday. Deutsche Bank Aktiengesellschaft upgraded Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating and upped their price target for the stock from $20.00 to $26.00 in a research note on Friday, March 4th. Zacks Investment Research downgraded Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating and set a $23.00 price target on the stock. in a research note on Tuesday, March 29th. Finally, TheStreet upgraded Allscripts Healthcare Solutions from a “c+” rating to a “b” rating in a research note on Friday, February 25th. Four investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $22.00.

MDRX stock opened at $19.87 on Friday. Allscripts Healthcare Solutions has a fifty-two week low of $13.05 and a fifty-two week high of $23.25. The business’s 50 day moving average price is $21.72 and its two-hundred day moving average price is $19.09. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.39 and a current ratio of 1.39. The company has a market capitalization of $2.30 billion, a price-to-earnings ratio of 19.67, a price-to-earnings-growth ratio of 1.67 and a beta of 0.98.

Allscripts Healthcare Solutions (NASDAQ:MDRXGet Rating) last posted its earnings results on Thursday, May 5th. The software maker reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.03). Allscripts Healthcare Solutions had a return on equity of 10.91% and a net margin of 8.94%. The firm had revenue of $142.70 million for the quarter, compared to analysts’ expectations of $139.67 million. During the same quarter last year, the company posted $0.13 EPS. The firm’s revenue was up 6.7% on a year-over-year basis. Sell-side analysts forecast that Allscripts Healthcare Solutions will post 0.69 earnings per share for the current year.

In related news, CEO Paul Black sold 60,000 shares of the company’s stock in a transaction that occurred on Thursday, March 10th. The stock was sold at an average price of $21.87, for a total value of $1,312,200.00. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Richard J. Poulton sold 10,000 shares of the stock in a transaction on Tuesday, February 15th. The shares were sold at an average price of $20.83, for a total value of $208,300.00. The disclosure for this sale can be found here. Corporate insiders own 1.91% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. C M Bidwell & Associates Ltd. bought a new position in shares of Allscripts Healthcare Solutions during the 1st quarter valued at $44,000. Maverick Capital Ltd. bought a new position in shares of Allscripts Healthcare Solutions during the 3rd quarter valued at $55,000. CIBC Asset Management Inc bought a new position in shares of Allscripts Healthcare Solutions during the 4th quarter valued at $200,000. Janus Henderson Group PLC bought a new position in shares of Allscripts Healthcare Solutions during the 3rd quarter valued at $213,000. Finally, Man Group plc bought a new position in shares of Allscripts Healthcare Solutions during the 3rd quarter valued at $228,000.

Allscripts Healthcare Solutions Company Profile (Get Rating)

Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Articles

The Fly logo

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)



Receive News & Ratings for Allscripts Healthcare Solutions Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com’s FREE daily email newsletter.

link

Leave a Reply

Your email address will not be published. Required fields are marked *